help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kindblom, L. G.
Right arrow Articles by Meis-Kindblom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kindblom, L. G.
Right arrow Articles by Meis-Kindblom, J. M.

American Journal of Pathology, Vol 152, 1259-1269, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal

LG Kindblom, HE Remotti, F Aldenborg and JM Meis-Kindblom
Department of Pathology, Gothenburg Musculoskeletal Tumor Center, University of Gothenburg, Sahlgrenska University Hospital, Sweden.

The interstitial cells of Cajal (ICC) form a complex cell network within the gastrointestinal tract wall where they function as a pacemaker system. Expression of the kit proto-oncogene is essential for the development of this system. The aim of our study was to examine the hypothesis that gastrointestinal stromal tumors differentiate toward cells with an ICC phenotype. Ultrastructurally, 58 stromal tumors were characterized and found to share many features with ICC. Seventy-eight stromal tumors were immunophenotyped, particularly with regard to the kit receptor. All 78 tumors revealed strong, homogeneous immunoreactivity for the kit receptor as did ICC of adjacent and control gastrointestinal walls. Focal hyperplasia and hypertrophy of kit receptor positive cells were also observed in the gastrointestinal wall adjacent to the tumors. CD34 immunoreactivity observed in interstitial cells surrounding Auerbach's ganglia suggests that a subpopulation of ICC is CD34 positive and may explain why 56 of 78 stromal tumors were CD34 positive. Thirty control tumors, including gastrointestinal leiomyomas and leiomyosarcomas, were all negative for the kit receptor. We conclude that gastrointestinal stromal tumors show striking morphological and immunophenotypic similarities with ICC and that they may originate from stem cells that differentiate toward a pacemaker cell phenotype. We propose that the noncommittal name "gastrointestinal stromal tumor" be replaced by gastrointestinal pacemaker cell tumor.


This article has been cited by other articles:


Home page
 INT J SURG PATHOLHome page
B. M. Yan, G. G. Kaplan, S. Urbanski, C. L. Nash, and P. L. Beck
Epidemiology of Gastrointestinal Stromal Tumors in a Defined Canadian Health Region: A Population-Based Study
International Journal of Surgical Pathology, July 1, 2008; 16(3): 241 - 250.
[Abstract] [PDF]

Home page
 Arch SurgHome page
K. L. Huguet, R. M. Rush Jr, D. J. Tessier, R. T. Schlinkert, R. A. Hinder, G. G. Grinberg, M. L. Kendrick, and K. L. Harold
Laparoscopic Gastric Gastrointestinal Stromal Tumor Resection: The Mayo Clinic Experience
Arch Surg, June 1, 2008; 143(6): 587 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. C. McAuliffe, A. J.F. Lazar, D. Yang, D. M. Steinert, W. Qiao, P. F. Thall, A. K. Raymond, R. S. Benjamin, and J. C. Trent
Association of Intratumoral Vascular Endothelial Growth Factor Expression and Clinical Outcome for Patients with Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate
Clin. Cancer Res., November 15, 2007; 13(22): 6727 - 6734.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
G. Portale, G. Zaninotto, M. Costantini, M. Rugge, G. M. Pennelli, S. Rampado, P. Bocus, and E. Ancona
Esophageal GIST: Case Report of Surgical Enucleation and Update on Current Diagnostic and Therapeutic Options
International Journal of Surgical Pathology, October 1, 2007; 15(4): 393 - 396.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Desai, S. Shankar, M. C. Heinrich, J. A. Fletcher, C. D. Fletcher, J. Manola, J. A. Morgan, C. L. Corless, S. George, K. Tuncali, et al.
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors
Clin. Cancer Res., September 15, 2007; 13(18): 5398 - 5405.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P. Bumming, O. Nilsson, H. Ahlman, A. Welbencer, M. K Andersson, K. Sjolund, and B. Nilsson
Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype
Endocr. Relat. Cancer, September 1, 2007; 14(3): 853 - 863.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Matyakhina, T. A. Bei, S. R. McWhinney, B. Pasini, S. Cameron, B. Gunawan, S. G. Stergiopoulos, S. Boikos, M. Muchow, A. Dutra, et al.
Genetics of Carney Triad: Recurrent Losses at Chromosome 1 but Lack of Germline Mutations in Genes Associated with Paragangliomas and Gastrointestinal Stromal Tumors
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2938 - 2943.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
P. Rutkowski, Z. I. Nowecki, W. Michej, M. Debiec-Rychter, A. Wozniak, J. Limon, J. Siedlecki, U. Grzesiakowska, M. Kakol, C. Osuch, et al.
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor
Ann. Surg. Oncol., July 1, 2007; 14(7): 2018 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
F. Grabellus, P. Ebeling, K. Worm, S.-Y. Sheu, G. Antoch, A. Frilling, and K. W Schmid
Double resistance to imatinib and AMG 706 caused by multiple acquired KIT exon 17 mutations in a gastrointestinal stromal tumour
Gut, July 1, 2007; 56(7): 1025 - 1026.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. S. Yoon and K. K. Tanabe
Should Surgical Resection Be Combined with Imatinib Therapy for Locally Advanced or Metastatic Gastrointestinal Stromal Tumors?
Ann. Surg. Oncol., June 1, 2007; 14(6): 1784 - 1786.
[Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
A. Zamo, A. Bertolaso, I. Franceschetti, G. Weirich, P. Capelli, S. Pecori, M. Chilosi, H. Hoefler, F. Menestrina, and A. Scarpa
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation
J. Mol. Diagn., April 1, 2007; 9(2): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
F. R. Jamali, S. S. Darwiche, N. El-Kinge, A. Tawil, and A. M. Soweid
Disease Progression Following Imatinib Failure in Gastrointestinal Stromal Tumors: Role of Surgical Therapy
Oncologist, April 1, 2007; 12(4): 438 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C.-N. Yeh, T.-W. Chen, H.-L. Lee, Y.-Y. Liu, T.-C. Chao, T.-L. Hwang, Y.-Y. Jan, and M.-F. Chen
Kinase Mutations and Imatinib Mesylate Response for 64 Taiwanese with Advanced GIST: Preliminary Experience from Chang Gung Memorial Hospital
Ann. Surg. Oncol., March 1, 2007; 14(3): 1123 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
F. Haller, S. Detken, H.-J. Schulten, N. Happel, B. Gunawan, J. Kuhlgatz, and L. Fuzesi
Surgical Management After Neoadjuvant Imatinib Therapy in Gastrointestinal Stromal Tumours (GISTs) with Respect to Imatinib Resistance Caused by Secondary KIT Mutations
Ann. Surg. Oncol., February 1, 2007; 14(2): 526 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. H. I. Andtbacka, C. S. Ng, C. L. Scaife, J. N. Cormier, K. K. Hunt, P. W. T. Pisters, R. E. Pollock, R. S. Benjamin, M. A. Burgess, L. L. Chen, et al.
Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib
Ann. Surg. Oncol., January 1, 2007; 14(1): 14 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S. Ekeblad, B. Nilsson, M. H. Lejonklou, T. Johansson, P. Stalberg, O. Nilsson, H. Ahlman, and B. Skogseid
Gastrointestinal stromal tumors express the orexigen ghrelin.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 963 - 970.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
L Tornillo and L M Terracciano
An update on molecular genetics of gastrointestinal stromal tumours.
J. Clin. Pathol., June 1, 2006; 59(6): 557 - 563.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Tarn, Y. V. Skorobogatko, T. Taguchi, B. Eisenberg, M. von Mehren, and A. K. Godwin
Therapeutic Effect of Imatinib in Gastrointestinal Stromal Tumors: AKT Signaling Dependent and Independent Mechanisms.
Cancer Res., May 15, 2006; 66(10): 5477 - 5486.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
O. Maertens, H. Prenen, M. Debiec-Rychter, A. Wozniak, R. Sciot, P. Pauwels, I. De Wever, J. R. Vermeesch, T. de Raedt, A. De Paepe, et al.
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
Hum. Mol. Genet., March 15, 2006; 15(6): 1015 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
H. Fujimoto, M. Shibutani, K. Kuroiwa, K. Inoue, G.-H. Woo, M. U, and M. Hirose
A Case Report of a Spontaneous Gastrointestinal Stromal Tumor (GIST) Occurring in a F344 Rat
Toxicol Pathol, February 1, 2006; 34(2): 164 - 167.
[Abstract] [PDF]

Home page
 JCOHome page
J. Martin, A. Poveda, A. Llombart-Bosch, R. Ramos, J. A. Lopez-Guerrero, J. G. del Muro, J. Maurel, S. Calabuig, A. Gutierrez, J. L. G. de Sande, et al.
Deletions Affecting Codons 557-558 of the c-KIT Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)
J. Clin. Oncol., September 1, 2005; 23(25): 6190 - 6198.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
G Rossi, G Sartori, R Valli, F Bertolini, N Bigiani, L Schirosi, A Cavazza, and G Luppi
The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour
J. Clin. Pathol., September 1, 2005; 58(9): 991 - 993.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. A. Clark, C. Fisher, I. Judson, and J. M. Thomas
Soft-Tissue Sarcomas in Adults
N. Engl. J. Med., August 18, 2005; 353(7): 701 - 711.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
B. P. Rubin, C. R. Antonescu, J. P. Scott-Browne, M. L. Comstock, Y. Gu, M. R. Tanas, C. B. Ware, and J. Woodell
A Knock-In Mouse Model of Gastrointestinal Stromal Tumor Harboring Kit K641E
Cancer Res., August 1, 2005; 65(15): 6631 - 6639.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
R Penzel, S Aulmann, M Moock, M Schwarzbach, R J Rieker, and G Mechtersheimer
The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated
J. Clin. Pathol., June 1, 2005; 58(6): 634 - 639.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Chugh, R. Dunn, M. M. Zalupski, J. S. Biermann, V. K. Sondak, J. R. Mace, K. M. Leu, W. F. Chandler, and L. H. Baker
Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma
J. Clin. Oncol., May 20, 2005; 23(15): 3597 - 3604.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Tarn, E. Merkel, A. A. Canutescu, W. Shen, Y. Skorobogatko, M. J. Heslin, B. Eisenberg, R. Birbe, A. Patchefsky, R. Dunbrack, et al.
Analysis of KIT Mutations in Sporadic and Familial Gastrointestinal Stromal Tumors: Therapeutic Implications through Protein Modeling
Clin. Cancer Res., May 15, 2005; 11(10): 3668 - 3677.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
U. De Giorgi and J. Verweij
Imatinib and gastrointestinal stromal tumors: Where do we go from here?
Mol. Cancer Ther., March 1, 2005; 4(3): 495 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Uccini, O. Mannarino, H. P. McDowell, U. Pauser, R. Vitali, P. G. Natali, P. Altavista, T. Andreano, S. Coco, R. Boldrini, et al.
Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors
Clin. Cancer Res., January 1, 2005; 11(1): 380 - 389.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. D. Demetri, R. L. Titton, D. P. Ryan, and C. D.M. Fletcher
Case 32-2004 - A 68-Year-Old Man with a Large Retroperitoneal Mass
N. Engl. J. Med., October 21, 2004; 351(17): 1779 - 1787.
[Full Text] [PDF]

Home page
 JCOHome page
C. L. Corless, J. A. Fletcher, and M. C. Heinrich
Biology of Gastrointestinal Stromal Tumors
J. Clin. Oncol., September 15, 2004; 22(18): 3813 - 3825.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Duensing, N. E. Joseph, F. Medeiros, F. Smith, J. L. Hornick, M. C. Heinrich, C. L. Corless, G. D. Demetri, C. D. M. Fletcher, and J. A. Fletcher
Protein Kinase C {theta} (PKC{theta}) Expression and Constitutive Activation in Gastrointestinal Stromal Tumors (GISTs)
Cancer Res., August 1, 2004; 64(15): 5127 - 5131.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Blay, A. Astudillo, J. M. Buesa, E. Campo, M. Abad, J. Garcia-Garcia, R. Miquel, V. Marco, M. Sierra, R. Losa, et al.
Protein Kinase C {theta} Is Highly Expressed in Gastrointestinal Stromal Tumors But Not in Other Mesenchymal Neoplasias
Clin. Cancer Res., June 15, 2004; 10(12): 4089 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. L. Eisenberg and I. Judson
Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant Therapy
Ann. Surg. Oncol., May 1, 2004; 11(5): 465 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. W. Kim, H. Lee, Y.-K. Kang, M. S. Choe, M.-H. Ryu, H. M. Chang, J. S. Kim, J. H. Yook, B. S. Kim, and J. S. Lee
Prognostic Significance of c-kit Mutation in Localized Gastrointestinal Stromal Tumors
Clin. Cancer Res., May 1, 2004; 10(9): 3076 - 3081.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Bono, A. Krause, M. von Mehren, M. C. Heinrich, C. D. Blanke, S. Dimitrijevic, G. D. Demetri, and H. Joensuu
Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
Blood, April 15, 2004; 103(8): 2929 - 2935.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
J. N. Cormier and R. E. Pollock
Soft Tissue Sarcomas
CA Cancer J Clin, March 1, 2004; 54(2): 94 - 109.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N Koon, R Schneider-Stock, M Sarlomo-Rikala, J Lasota, M Smolkin, G Petroni, A Zaika, C Boltze, F Meyer, L Andersson, et al.
Molecular targets for tumour progression in gastrointestinal stromal tumours
Gut, February 1, 2004; 53(2): 235 - 240.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
K.-W. Min
Gist or Gant?
International Journal of Surgical Pathology, October 1, 2003; 11(4): 357 - 358.
[PDF]

Home page
 Clin. Cancer Res.Home page
C. R. Antonescu, G. Sommer, L. Sarran, S. J. Tschernyavsky, E. Riedel, J. M. Woodruff, M. Robson, R. Maki, M. F. Brennan, M. Ladanyi, et al.
Association of KIT Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: KIT Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors
Clin. Cancer Res., August 1, 2003; 9(9): 3329 - 3337.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
J. Rosai
GIST: An Update
International Journal of Surgical Pathology, July 1, 2003; 11(3): 177 - 186.
[PDF]

Home page
 Am. J. Roentgenol.Home page
A. D. Levy, H. E. Remotti, W. M. Thompson, L. H. Sobin, and M. Miettinen
Anorectal Gastrointestinal Stromal Tumors: CT and MR Imaging Features with Clinical and Pathologic Correlation
Am. J. Roentgenol., June 1, 2003; 180(6): 1607 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. R. Choi, H. Kim, H. J. Kang, N.-G. Kim, J. J. Kim, K.-S. Park, Y.-K. Paik, H. O. Kim, and H. Kim
Overexpression of High Mobility Group Box 1 in Gastrointestinal Stromal Tumors with KIT Mutation
Cancer Res., May 1, 2003; 63(9): 2188 - 2193.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Schneider-Stock, C. Boltze, J. Lasota, M. Miettinen, B. Peters, M. Pross, A. Roessner, and T. Gunther
High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors
J. Clin. Oncol., May 1, 2003; 21(9): 1688 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. H. Segal, P. Pavlidis, W. S. Noble, C. R. Antonescu, A. Viale, U. V. Wesley, K. Busam, H. Gallardo, D. DeSantis, M. F. Brennan, et al.
Classification of Clear-Cell Sarcoma as a Subtype of Melanoma by Genomic Profiling
J. Clin. Oncol., May 1, 2003; 21(9): 1775 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
T Tornoczky, E Kover, and L Pajor
Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours
J. Clin. Pathol., May 1, 2003; 56(5): 363 - 367.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
A. D. Levy, H. E. Remotti, W. M. Thompson, L. H. Sobin, and M. Miettinen
From the Archives of the AFIP: Gastrointestinal Stromal Tumors: Radiologic Features with Pathologic Correlation
RadioGraphics, March 1, 2003; 23(2): 283 - 304.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. J. C. Burkill, M. Badran, O. Al-Muderis, J. Meirion Thomas, I. R. Judson, C. Fisher, and E. C. Moskovic
Malignant Gastrointestinal Stromal Tumor: Distribution, Imaging Features, and Pattern of Metastatic Spread
Radiology, February 1, 2003; 226(2): 527 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
D. Frost, J. Lasota, and M. Miettinen
Gastrointestinal Stromal Tumors and Leiomyomas in the Dog: A Histopathologic, Immunohistochemical, and Molecular Genetic Study of 50 Cases
Vet. Pathol., January 1, 2003; 40(1): 42 - 54.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Chen, S Hirota, K Isozaki, H Sun, A Ohashi, K Kinoshita, P O'Brien, L Kapusta, I Dardick, T Obayashi, et al.
Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours
Gut, December 1, 2002; 51(6): 793 - 796.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
R. P. DeMatteo
The GIST of Targeted Cancer Therapy: A Tumor (Gastrointestinal Stromal Tumor), a Mutated Gene (c-kit), and a Molecular Inhibitor (STI571)
Ann. Surg. Oncol., November 1, 2002; 9(9): 831 - 839.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. J. Frost, P. T. Ferrao, T. P. Hughes, and L. K. Ashman
Juxtamembrane Mutant V560GKit Is More Sensitive to Imatinib (STI571) Compared with Wild-Type c-Kit Whereas the Kinase Domain Mutant D816VKit Is Resistant
Mol. Cancer Ther., October 1, 2002; 1(12): 1115 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Singer, B. P. Rubin, M. L. Lux, C.-J. Chen, G. D. Demetri, C. D.M. Fletcher, and J. A. Fletcher
Prognostic Value of KIT Mutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal Tumors
J. Clin. Oncol., September 15, 2002; 20(18): 3898 - 3905.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
X. Wang, I. Mori, W. Tang, H. Utsunomiya, M. Nakamura, Y. Nakamura, G. Zhou, and K. Kennichi
Helpful Parameter for Malignant Potential of Gastrointestinal Stromal Tumors (GIST)
Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 347 - 351.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
C. D. M. Fletcher, J. J. Berman, C. Corless, F. Gorstein, J. Lasota, B. J. Longley, M. Miettinen, T. J. O'Leary, H. Remotti, B. P. Rubin, et al.
Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach
International Journal of Surgical Pathology, April 1, 2002; 10(2): 81 - 89.
[Abstract] [PDF]

Home page
 INT J SURG PATHOLHome page
R. K. Yantiss, A. E. Rosenberg, M. K. Selig, and G. P. Nielsen
Gastrointestinal Stromal Tumors: An Ultrastructural Study
International Journal of Surgical Pathology, April 1, 2002; 10(2): 101 - 113.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
J. Andersson, H. Sjogren, J. M. Meis-Kindblom, G. Stenman, P. Aman, and L.-G. Kindblom
The Complexity of KIT Gene Mutations and Chromosome Rearrangements and Their Clinical Correlation in Gastrointestinal Stromal (Pacemaker Cell) Tumors
Am. J. Pathol., January 1, 2002; 160(1): 15 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. V. Allander, N. N. Nupponen, M. Ringner, G. Hostetter, G. W. Maher, N. Goldberger, Y. Chen, J. Carpten, A. G. Elkahloun, and P. S. Meltzer
Gastrointestinal Stromal Tumors with KIT Mutations Exhibit a Remarkably Homogeneous Gene Expression Profile
Cancer Res., December 1, 2001; 61(24): 8624 - 8628.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. P. Rubin, S. Singer, C. Tsao, A. Duensing, M. L. Lux, R. Ruiz, M. K. Hibbard, C.-J. Chen, S. Xiao, D. A. Tuveson, et al.
KIT Activation Is a Ubiquitous Feature of Gastrointestinal Stromal Tumors
Cancer Res., November 1, 2001; 61(22): 8118 - 8121.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. R. Howe, L. H. Karnell, and C. Scott-Conner
Small Bowel Sarcoma: Analysis of Survival From the National Cancer Data Base
Ann. Surg. Oncol., July 1, 2001; 8(6): 496 - 508.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. J. Mauro and B. J. Druker
STI571: Targeting BCR-ABL as Therapy for CML
Oncologist, June 1, 2001; 6(3): 233 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. M. Clary, R. P. DeMatteo, J. J. Lewis, D. Leung, and M. F. Brennan
Gastrointestinal Stromal Tumors and Leiomyosarcoma of the Abdomen and Retroperitoneum: A Clinical Comparison
Ann. Surg. Oncol., April 1, 2001; 8(4): 290 - 299.
[Abstract] [Full Text] [PDF]

Home page